Antioxidant and B-vitamins and Atherosclerosis

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/978-1-60327-542-2_12
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.

  2010cited by this paper
• Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.

  2008cited by this paper
• Atherosclerosis and oxidative stress.

  2008cited by this paper
• Both α- and β-Carotene, but Not Tocopherols and Vitamin C, Are Inversely Related to 15-Year Cardiovascular Mortality in Dutch Elderly Men

  2008cited by this paper
• Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.

  2008cited by this paper
• Pro-thrombotic and pro-oxidant effects of diet-induced hyperhomocysteinemia.

  2007cited by this paper
• Vascular Oxidant Stress and Inflammation in Hyperhomocysteinemia

  2007cited by this paper
• Lipid peroxidation and redox-sensitive signaling pathways

  2007cited by this paper
• Nutrition, physical activity, and cardiovascular disease: an update.

  2007cited by this paper
• Homocysteine-Lowering Therapy and Risk for Venous Thromboembolism

  2007cited by this paper
• Heart disease and single-vitamin supplementation.

  2007cited by this paper
• Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype: A Prospective Double-Blinded Clinical Trial

  2007cited by this paper
• Atherosclerosis and Oxidant Stress: The End of the Road for Antioxidant Vitamin Treatment?

  2007cited by this paper
• Effect of high-dose α-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease

  2007cited by this paper
• Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial.

  2006cited by this paper
• Alpha tocopherol supplementation elevates plasma apolipoprotein A1 isoforms in normal healthy subjects

  2006cited by this paper
• Homocysteine lowering and cardiovascular events after acute myocardial infarction.

  2006cited by this paper
• Initiation and progression of atherosclerosis – enzymatic or oxidative modification of low-density lipoprotein?

  2006cited by this paper
• Homocysteine-Lowering Vitamin B Treatment Decreases Cardiovascular Events in Hemodialysis Patients

  2006cited by this paper
• [Homocysteine lowering with folic acid and B vitamins in vascular disease].

  2006cited by this paper
• Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.

  2006cited by this paper
• Plasma carotene and alpha-tocopherol in relation to 10-y all-cause and cause-specific mortality in European elderly: the Survey in Europe on Nutrition and the Elderly, a Concerted Action (SENECA).

  2005cited by this paper
• Vitamin E, oxidative stress, and inflammation.

  2005cited by this paper
• Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

  2005cited by this paper
• Sustained Homocysteine-Lowering Effect over Time of Folic Acid-Based Multivitamin Therapy in Stroke Patients despite Increasing Folate Status in the Population

  2005cited by this paper
• Vitamin E Modulation of Cardiovascular Disease

  2004cited by this paper
• Folate Therapy and In-Stent Restenosis after Coronary Stenting

  2004cited by this paper
• Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

  2004cited by this paper
• Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease.

  2004cited by this paper
• Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke Basel Prospective Study

  2004cited by this paper
• Folate Intake and Risk of Stroke Among Women

  2004cited by this paper
• The role of carotenoids in the prevention of human pathologies.

  2004cited by this paper
• Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology.

  2004cited by this paper
• Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention.

  2004cited by this paper
• The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.

  2004cited by this paper
• Oxidative Stress and Vascular Disease

  2004cited by this paper
• Secondary prevention with folic acid: effects on clinical outcomes.

  2003cited by this paper
• Mechanisms of oxidative stress and vascular dysfunction

  2003cited by this paper
• Saturday 28 November 1981 DIETARY VITAMIN A AND RISK OF CANCER IN THE WESTERN ELECTRIC STUDY

  2003cited by this paper
• Folate, Vitamin B6, and B12 Intakes in Relation to Risk of Stroke Among Men

  2003cited by this paper
• Six-Year Effect of Combined Vitamin C and E Supplementation on Atherosclerotic Progression: The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study

  2003cited by this paper
• Oxidative stress and cardiovascular injury: Part II: animal and human studies.

  2003cited by this paper
• Oxidative stress, exercise, and antioxidant supplementation.

  2003cited by this paper
• Does Homocysteine Cause Hypertension?

  2003cited by this paper
• Endothelial Dysfunction: A Marker of Atherosclerotic Risk

  2003cited by this paper
• Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients.

  2003cited by this paper
• Role of oxidative stress in atherosclerosis.

  2003cited by this paper
• Role of fine needle aspiration biopsy in differential diagnosis of liver echinococcosis

  2003cited by this paper
• Oral a-tocopherol Supplementation Inhibits Lipid Oxidation in Established Human Atherosclerotic Lesions

  2003cited by this paper
• Alpha-Tocopherol Supplementation in Healthy Individuals Reduces Low-Density Lipoprotein Oxidation but Not Atherosclerosis: The Vitamin E Atherosclerosis Prevention Study (VEAPS)

  2002cited by this paper
• The VITATOPS (Vitamins to Prevent Stroke) Trial: Rationale and Design of an International, Large, Simple, Randomised Trial of Homocysteine-Lowering Multivitamin Therapy in Patients with Recent Transient Ischaemic Attack or Stroke

  2002cited by this paper
• Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• First News of the Battle of Lexington

  2002cited by this paper
• Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.

  2002cited by this paper
• Homocysteine and cardiovascular disease: current evidence and future prospects.

  2002cited by this paper
• Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Dietary Intake of Folate and Risk of Stroke in US Men and Women: NHANES I Epidemiologic Follow-Up Study

  2002cited by this paper
• MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

  2002cited by this paper
• Drink in moderation, says consensus panel

  2001cited by this paper
• Oxidant stress and endothelial cell dysfunction.

  2001cited by this paper
• Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.

  2001cited by this paper
• Primäre Prävention kardiovaskulärer Ereignisse durch ASS und Vitamin E PPP das “Primary Prevention Project”

  2001cited by this paper
• Effects of Ramipril and Vitamin E on Atherosclerosis: The Study to Evaluate Carotid Ultrasound Changes in Patients Treated With Ramipril and Vitamin E (SECURE)

  2001cited by this paper
• Power Shortage: Clinical Trials Testing the Homocysteine Hypothesis against a Background of Folic AcidFortified Cereal Grain Flour

  2001cited by this paper
• Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3‐year progression of carotid atherosclerosis

  2000cited by this paper
• Vitamin E supplementation and cardiovascular events in high-risk patients.

  2000cited by this paper
• Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.

  2000cited by this paper
• Serum carotenoids and atherosclerosis. The Rotterdam Study.

  2000cited by this paper
• NAD(P)H oxidase: role in cardiovascular biology and disease.

  2000cited by this paper
• Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women.

  2000cited by this paper
• Low serum folate concentrations are associated with an excess incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study

  2000cited by this paper
• Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography.

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

  1999cited by this paper
• β-Carotene Supplementation and Incidence of Cancer and Cardiovascular Disease: the Women's Health Study.

  1999cited by this paper
• Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

  1999cited by this paper
• The effect of folic acid fortification on plasma folate and total homocysteine concentrations.

  1999cited by this paper
• Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial.

  1999cited by this paper
• Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study.

  1999cited by this paper
• alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state.

  1998cited by this paper
• Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.

  1998cited by this paper
• Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.

  1998cited by this paper
• Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

  1998cited by this paper
• Arterial injury by cholesterol oxidation products causes endothelial dysfunction and arterial wall cholesterol accumulation.

  1998cited by this paper
• The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events

  1998cited by this paper
• Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease.

  1998cited by this paper
• Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women.

  1998cited by this paper
• Serum Ascorbic Acid and Cardiovascular Disease Prevalence in U.S. Adults

  1998cited by this paper
• Variability in the measurement of intracoronary ultrasound images: implicatioNs for the identification of atherosclerotic plaque regression

  1997cited by this paper
• Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction

  1997cited by this paper
• First myocardial infarction in patients of Indian subcontinent and European origin: comparison of risk factors, management, and long term outcome

  1997cited by this paper
• Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and C.

  1997cited by this paper
• The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.

  1997cited by this paper
• Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study

  1997cited by this paper
• Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: The EVA Study. Etude sur le Vieillisement Artériel.

  1997cited by this paper
• Endothelial Function and Oxidant Stress

  1997cited by this paper
• Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study. The ARIC Study Investigators. Atherosclerosis Risk in Communities.

  1997cited by this paper

• Haptoglobin Genotype and a Promising Pharmacogenomic Approach to Prevent Diabetic Atherothrombosis with Vitamin E Supplementation

  2019cites this paper
• Nutritional Assessment of Monochoria vaginalis, a Wild Edible Vegetable Supplement to the Human Diet

  2012cites this paper